The 3 best performing ASX shares in the week of 7 November 2022

Marc Kennis Marc Kennis, November 14, 2022

The 3 best performing ASX shares in the week of 7 November 2022

 

The 3 best performing ASX shares of the week starting 7 November 2022 were Invictus Energy (ASX:IVZ), up 108.7%, Aeris Resources (ASX:AIS), up 57.8%, and Novatti Group (ASX:NOV), up 43.2%.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Invictus Energy (ASX:IVZ)

Industry: Energy

Invictus Energy (ASX:IVZ) is an independent upstream oil and gas company. The company is opening rift basins in onshore Africa – the Cabora Bassa Basin – in northern Zimbabwe through a high impact exploration program.

Market Cap: $210m

12 month high / low: $0.10 – $0.36

 

 

 

2. Aeris Resources (ASX:AIS)

Industry: Resources

Aeris Resources (ASX:AIS) is a diversified mining and exploration company listed on the Australian Securities Exchange and headquartered in Brisbane, Queensland. During the year the company is involved in production and sale of copper, gold and silver and the exploration for copper and gold.

Market Cap: $349m

12 month high / low: $0.275 – $1.20

 

 

 

3. Novatti Group (ASX:NOV)

Industry: Industrials

Novatti Group (ASX:NOV) rounds out our 3 best performing ASX shares this week. NOV is a payment processing platform that facilitates mobile and alternative financial payments solutions and services.

Market Cap: $92m

12 month high / low: $0.15 – $0.43

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

Recent Posts

rule of 72

Rule of 72: Here’s how investors can use it to their advantage

Here’s why The Rule of 72 might be useful to consider when investing in Stocks Investing in stocks can be…

Novo Nordisk

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$400bn company behind obesity drug Ozempic

Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year, but Novo Nordisk (CPH:…

Bapcor

Bapcor (ASX:BAP): Its been a horror week with a 3rd profit downgrade in less than a year

This week investors in Bapcor (ASX:BAP) saw a 3rd profit downgrade in less than a year and its CEO-elect walk…